Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells

Molecular and Cellular Biology

Volumn 23, Issue 6, 2003, Pages 1994-2008

  Ballaré, Cecilia ^a,b   Uhrig, Markus ^a   Bechtold, Thomas ^a,b   Sancho, Elena ^a,d   Di Domenico, Marina ^c   Migliaccio, Antimo ^c   Auricchio, Ferdinando ^c   Beato, Miguel ^a,b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE; PROGESTERONE RECEPTOR;

ANIMAL CELL; ARTICLE; BREAST CANCER; CELL STRAIN COS7; CONTROLLED STUDY; GENE DELETION; GENETIC TRANSFECTION; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; IMMUNOPRECIPITATION; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANIMALS; BREAST NEOPLASMS; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME ACTIVATION; ESTROGEN RECEPTOR ALPHA; GENES, REPORTER; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PROGESTERONE; PROTEIN INTERACTION MAPPING; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SRC HOMOLOGY DOMAINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR CELLS, CULTURED; TWO-HYBRID SYSTEM TECHNIQUES;

ANIMALIA; MAMMALIA;

EID: 0037371863     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.6.1994-2008.2003     Document Type: Article

References (40)

1. Aronica, S. M., and B. S. Katzenellenbogen. 1993. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1. Mol. Endocrinol. 7:743-752.
2. Barettino, D., M. D. M. V. Ruiz, and H. G. Stunnenberg. 1994. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J. 13:3039-3049.
3. Beato, M., P. Herrlich, and G. Schütz. 1995. Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857.
4. Boonyaratanakornkit, V., M. P. Scott, V. Ribon, L. Sherman, S. M. Anderson, J. L. Maller, W. T. Miller, and D. P. Edwards. 2001. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell 8:269-280.
5. Brown, C. E., T. Lechner, L. Howe, and J. L. Workman. 2000. The many HATs of transcription coactivators. Trends Biochem. Sci. 25:15-19.
6. Brüggemeier, U., L. Rogge, E. L. Winnacker, and M. Beato. 1990. Nuclear factor I acts as a transcription factor on the MMTV promoter but competes with steroid hormone receptors for DNA binding. EMBO J. 9:2233-2239.
7. Castoria, G., M. V. Barone, M. Di Domenico, A. Bilancio, D. Ametrano, A. Migliaccio, and F. Auricchio. 1999. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J. 18:2500-2510.
8. Castoria, G., A. Migliaccio, A. Bilancio, M. Di Domenico, A. de Falco, M. Lombardi, R. Fiorentino, L. Varricchio, M. V. Barone, and F. Auricchio. 2001. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 20:6050-6059.
9. Castoria, G., A. Migliaccio, S. Green, M. Di Domenico, P. Chambon, and F. Auricchio. 1993. Properties of a purified estradiol-dependent calf uterus tyrosine kinase. Biochemistry 32:1740-1750.
10. Cavaillès, V., S. Dauvois, P. S. Danielian, and M. G. Parker. 1994. Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl. Acad. Sci. USA 91:10009-10013.
11. Chalbos, D., and F. Galtier. 1994. Differential effect of forms A and B of human progesterone receptor on estradiol-dependent transcription. J. Biol. Chem. 269:23007-23012.
12. Chalepakis, G., J. Arnemann, E. P. Slater, H. Brüller, B. Gross, and M. Beato. 1988. Differential gene activation by glucocorticoids and progestins through them hormone regulatory element of mouse mammary tumor virus. Cell 53:371-382.
13. Clarke, C. L., and R. L. Sutherland. 1990. Progestin regulation of cellular proliferation. Endocr. Rev. 11:266-301.
14. Clemm, D. L., L. Sherman, V. Boonyaratanakornkit, W. T. Schrader, N. L. Weigel, and D. P. Edwards. 2000. Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody. Mol. Endocrinol. 14:52-65.
15. Collins, P., and C. Webb. 1999. Estrogen hits the surface. Nat. Med. 5:1130-1131.
16. Edwards, D. P., N. L. Weigel, S. K. Nordeen, and C. A. Beck. 1993. Modulators of cellular protein phosphorylation alter the trans-activation function of human progesterone receptor and the biological activity of progesterone antagonists. Breast Cancer Res. Treat. 27:41-56.
17. Frangioni, J. V., and B. G. Neel. 1993. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal. Biochem. 210:179-187.
18. Freedman, L. P. 1999. Increasing the complexity of coactivation in nuclear receptor signaling. Cell 97:5-8.
19. Gong, W., S. Chávez, and M. Beato. 1997. Point mutation in the ligand binding domain of the progesterone receptor generates a transdominant negative phenotype. Mol. Endocrinol. 11:1476-1485.
20. Grazzini, E., G. Guillon, B. Mouillac, and H. H. Zingg. 1998. Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 392:509-512.
21. Hovland, A. R., R. L. Powell, G. S. Takimoto, L. Tung, and K. B. Horwitz. 1998. An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors. J. Biol. Chem. 273:5455-5460.
22. Improta-Brears, T., A. R. Whorton, F. Codazzi, J. D. York, T. Meyer, and D. P. McDonnell. 1999. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc. Natl. Acad. Sci. USA 96:4686-4691.
23. Kastner, P., A. Krust, B. Turcotte, U. Stropp, L. Tora, H. Gronemeyer, and P. Chambon. 1990. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9:1603-1624.
24. Klehr, D., K. Maass, and J. Bode. 1991. Scaffold-attached regions from the human interferon β domain can be used to enhance the stable expression of genes under the control of various promoters. Biochemistry 30:1264-1270.
25. Kousteni, S., T. Bellido, L. I. Plotkin, C. A. O'Brien, D. L. Bodenner, L. Han, K. Han, G. B. DiGregorio, J. A. Katzenellenbogen, B. S. Katzenellenbogen, P. K. Roberson, R. S. Weinstein, R. L. Jilka, and S. C. Manolagas. 2001. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730.
26. Lange, C. A., J. K. Richer, and K. B. Horwitz. 1999. Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Mol. Endocrinol. 13:829-836.
27. Lim, C. S., C. T. Baumann, H. Htun, W. Xian, M. Irie, C. L. Smith, and G. L. Hager. 1999. Differential localization and activity of the A- and B-forms of the human progesterone receptor using green fluorescent protein chimeras. Mol. Endocrinol. 13:366-375.
28. Luttrell, D. K., A. Lee, T. J. Lansing, R. M. Crosby, K. D. Jung, D. Willard, M. Luther, M. Rodriguez, J. Berman, and T. M. Gilmer. 1994. Involvement of pp60c-src with two major signaling pathways in human breast cancer. Proc. Natl. Acad. Sci. USA 91:83-87.
29. Migliaccio, A., G. Castoria, M. Di Domenico, A. de Falco, A. Bilancio, M. Lombardi, M. V. Barone, D. Ametrano, M. S. Zannini, C. Abbondanza, and F. Auricchio. 2000. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J. 19:5406-5417.
30. Migliaccio, A., M. Di Domenico, G. Castoria, A. de Falco, P. Bontempo, E. Nola, and F. Auricchio. 1996. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15:1292-1300.
31. ras/erk pathway by progesterone receptor via a crosstalk with estrogen receptor. EMBO J. 17:2008-2018.
32. Peterziel, H., S. Mink, A. Schonert, M. Becker, H. Klocker, and A. C. Cato. 1999. Rapid signalling by androgen receptor in prostate cancer cells. Oncogene 18:6322-6329.
33. Sartorius, C. A., M. Y. Melville, A. R. Hovland, L. Tung, G. S. Takimoto, and K. B. Horwitz. 1994. A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol. Endocrinol. 8:1347-1360.
34. Schmidt, B. M., D. Gerdes, M. Feuring, E. Falkenstein, M. Christ, and M. Wehling. 2000. Rapid, nongenomic steroid actions: a new age? Front. Neuroendocrinol. 21:57-94.
35. Simoncini, T., A. Hafezi-Moghadam, D. P. Brazil, K. Ley, W. W. Chin, and J. K. Liao. 2000. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407:538-541.
36. Tora, L., A. Mullick, D. Metzger, M. Ponglikitmongkol, I. Park, and P. Chambon. 1989. The cloned human estrogen receptor contains a mutation which alters its hormone binding properties. EMBO J. 8:1981-1986.
37. Truss, M., J. Bartsch, and M. Beato. 1994. Antiprogestins prevent progesterone receptor binding to hormone responsive elements in vivo. Proc. Natl. Acad. Sci. USA 91:11333-11337.
38. Wehling, M. 1997. Specific, nongenomic actions of steroid hormones. Annu. Rev. Physiol. 59:365-393.
39. Weigel, N. L., and Y. Zhang. 1998. Ligand-independent activation of steroid hormone receptors. J. Mol. Med. 76:469-479.
40. Xie, D., C. W. Miller, J. O'Kelly, K. Nakachi, A. Sakashita, J. W. Said, J. Gornbein, and H. P. Koeffler. 2001. Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. J. Biol. Chem. 276:14187-14194.